Pharmaceutical companies can remain profitable while Americans pay lower medication prices under President Donald Trump’s plan for cutting costs, Dr. Mehmet Oz, the administrator for the Centers for Medicare and Medicaid Services, insisted on Newsmax Saturday.
“There are a lot of good reasons to have an executive order to address the inherent unfairness of American spending so much more than Europeans,” Oz said on Newsmax’s “America Right Now.” “We pointed out that there’s about a two to four times increase cost of medications in the United States compared to other competing companies that are similarly wealthy as we are. Does it make sense?”
He added that, as Trump pointed out, the United States is “literally subsidizing” the healthcare systems of other nations, meaning that “70% of the profits of the pharmaceutical industry are coming from Americans.”
Read more at Newsmax© 2025 Newsmax. All rights reserved.
